The yield on the benchmark 10-year Treasury note started the week on a tear, jumping to 2.99 percent and toying with the key 3 percent level that could trigger a reaction across global financial markets.
Martin Shkreli, the pharmaceutical industry entrepreneur whod been indicted on charges of securities fraud, had his Twitter account suspended Sunday after he recently harasseda female journalist online.
Lauren Duca, a freelance journalist whose work has appeared in Teen Vogue and other publications, tweeted Thursday a screenshot of a direct Twitter message from Shkreli, in which he invited....More>>>
After positive mid-stage trial data suggested earlier this year that it might be able to reshape the treatment of kidney failure in lupus patients, Aurinia Pharmaceuticals (NASDAQ:AUPH)has announced plans for a late-stage study that could eventually allow it to win regulatory OKs in the U.S., Europe, and Japan.
What’s going on
Aurinia Pharmaceuticals is working on voclosporin,....More>>>
A few days ago, an article about Nike (NYSE:NKE) argued that “Nike’s shares aren’t priced to buy.” The reasoning was that “Nike is, at best, fairly valued. And it certainly isn’t trading hands at fire-sale prices.” The question is: should you expect (and wait for) fire-sales prices? Most value investors know the maxim that it is better to buy a great business....More>>>
Before explaining and updating my version of the Celgene (NASDAQ:CELG) story, first, I’ll briefly explain and link to the 2 1/2-year story of my bullish-bearish-bullish evolution of views on this stock. This will help lay the groundwork to why I am again accentuating the positives, understanding there are negatives; the article goes into both sides of the CELG argument.
Airbus SE Chief Executive Officer Tom Enders sketched out the company’s plans for the next generation of European fighter aircraft and warned that Brexit means the U.K. could miss out on future production.
Airbus’s German operation is working with French warplane specialist
Picking stocks in a bull market is so easy the GEICO caveman could do it. After all, when the broader market indices, like the S&P 500, trade at average price-to-earnings (P/E) and price-to-sales ratios (P/S) of 24.4 and 2.2, respectively, just about every stock in the index is rising.
DFSCoin (CURRENCY:DFS) traded 6.4% higher against the US dollar during the one day period ending at 9:00 AM Eastern on April 21st. One DFSCoin coin can currently be purchased for about $0.0488 or 0.00000560 BTC on cryptocurrency exchanges including CoinExchange and Cryptopia. In the last seven